Vir Biotechnology Inc. (VIR) Tops Q3 EPS by 172c

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q3 EPS of $1.30, $1.72 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $374.6 million versus the consensus estimate of $146.35 million.

For earnings history and earnings-related data on Vir Biotechnology Inc. (VIR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Assurant (AIZ) is Piper Sandler's Weekly Focus Idea